Essential Nutrition Support Guidelines for GLP-1 Obesity Therapies: Insights from Top Health Organizations

Four key organizations—American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association, and The Obesity Society—recently collaborated on a clinical advisory titled "Nutritional Priorities to Support GLP-1 Therapy for Obesity." This guidance aims to help doctors support patients using GLP-1 medications for obesity with solid nutritional advice and lifestyle changes.

GLP-1 therapies are becoming increasingly popular in obesity management, leading to average weight losses of 5–18% in clinical trials. They also offer improvements in metabolic health and heart function. But it’s crucial to pair these medications with lifestyle changes, especially nutrition, to maintain long-term success.

Dr. Dariush Mozaffarian, the lead author, points out that while GLP-1s are a significant step forward in treating obesity, they come with challenges. These include digestive issues, nutrient deficiencies, and the potential for weight regain. He stresses that medication alone isn’t enough; proper nutrition and lifestyle support are vital for lasting results.

The advisory highlights eight essential nutritional priorities. These include:

1. Personalized therapy starts with a thorough assessment.
2. Manage any gastrointestinal side effects caused by medication.
3. Focus on nutrient-dense, minimally processed foods.
4. Prevent micronutrient deficiencies.
5. Ensure adequate protein intake to maintain muscle mass.
6. Use diet effectively to enhance weight loss.
7. Encourage other healthy lifestyle choices, like exercising, sleeping well, and managing stress.

Recent studies show that patients who combine GLP-1 therapy with structured nutritional guidance experience greater weight loss and are more likely to keep it off after stopping medication.

Despite these benefits, many patients prescribed GLP-1s do not receive adequate nutritional support. This advisory aims to bridge that gap and offer practical guidance for healthcare providers.

As obesity rates continue to rise globally, integrating nutritional therapy with GLP-1 treatment could enhance the effectiveness of these medications. Experts like Dr. John Courtney emphasize the importance of addressing lifestyle factors to optimize treatment outcomes and reduce healthcare costs.

The consensus on nutritional strategies is published across multiple reputable journals, ensuring wide accessibility. Researchers will discuss these findings at the upcoming NUTRITION 2025 conference in Orlando, where key insights on managing long-term GLP-1 therapy will be shared.

For further reading on nutrition and obesity management, visit the American Society for Nutrition.

Source link

GLP-1, Obesity, Bone, Education, Medicine, Muscle, Nutrition, Placebo, Receptor, Research, Weight Loss